Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in...

  • Main
  • 2020 / 10
  • Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in...

Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma

Izutsu, Koji, Yamamoto, Kazuhito, Kato, Koji, Ishikawa, Takayuki, Fukuhara, Noriko, Terui, Yasuhito, Choi, Ilseung, Humphrey, Kathryn, Kim, Su Young, Okubo, Sumiko, Ogawa, Natsumi, Nishimura, Yasuko,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
International Journal of Hematology
DOI:
10.1007/s12185-020-03024-3
Date:
October, 2020
File:
PDF, 944 KB
2020
Conversion to is in progress
Conversion to is failed